IMDRF Publishes Playbook for Medical Device Regulatory Reliance Programs on 26 February 2026

News Core Content

Publication and Purpose

According to the IMDRF document page, on 26 February 2026 IMDRF published the Playbook for Medical Device Regulatory Reliance Programs. The document provides a reference for regulators and industry to understand regulatory reliance, work-sharing and international convergence.

What Regulatory Reliance Means

Regulatory reliance does not mean that one country automatically recognizes another country's registration certificate. Instead, under specific conditions, a regulatory authority may reference, use or rely on the review conclusions, inspection results or technical documentation of another trusted regulatory authority, so as to improve resource efficiency and review consistency.

Implications for Companies

For companies, the trend toward regulatory reliance means that high-quality core technical documentation, consistency of dossiers across countries, evidence from established regulatory markets and post-market data are becoming increasingly important. If a company builds an internationalized documentation package from the outset, it will be better positioned when subsequently entering multiple GHWP member states and other markets.

AIMEILI Regulatory Interpretation

AIMEILI Regulatory Affairs Department considers that the most important lesson of IMDRF documents on regulatory reliance and international convergence for Chinese medical device companies is this: future multi-country registration competition will depend not only on a company's ability to submit in a single country, but also on whether it can establish a high-quality, reusable and explainable global registration master file. Regulatory reliance does not equal automatic mutual recognition, but it will make trusted market evidence, existing review conclusions, post-market data and quality management system consistency more valuable.

If a company reassembles documentation every time it enters a new country, not only is efficiency low, but inconsistencies may easily arise across countries in product names, models, intended use, labels, clinical evidence and risk management positions. By contrast, if a company establishes a global technical file, certificate matrix, label matrix, change matrix and post-market data matrix from the beginning, documentation conversion efficiency will improve significantly when entering GHWP member states, ASEAN, the Middle East, Africa and mature regulatory markets.

AIMEILI recommends that companies build a multi-country registration master file as go-global infrastructure rather than treating it as temporary documentation for a single project. The master file should cover at least product classification, technical description, risk management, performance verification, clinical evidence, quality management system, labels and instructions for use, UDI/traceability, post-market surveillance and a country differences table. In this way, companies can genuinely turn the trend of international regulatory convergence into a market access advantage.

Business Impact

This update may affect companies' assessment of registration pathways, preparation of technical files, labels and instructions for use, quality management system records and post-market maintenance arrangements. Companies should conduct an internal assessment based on target markets, product risk class, existing certificates and sales plans, rather than treating regulatory news as general information.

Compliance Actions for Companies

• Confirm whether the update affects existing registration pathways, certificate maintenance or post-market obligations.
• Verify technical files, labels and instructions for use, quality management system arrangements and local responsible entity arrangements in target countries.
• Establish change impact assessments and regulatory update tracking records for marketed products.
• Where necessary, archive the official original text, the regulatory interpretation and internal action items to support subsequent audits and project reviews.

Source and Scope

Source organization: IMDRF. Original date: 26 February 2026. Site publication date: 8 July 2026, 09:00. Original link: https://www.imdrf.org/documents/playbook-medical-device-regulatory-reliance-programs

This article is based on the IMDRF official page and is intended for preliminary understanding, documentation preparation and project planning. It does not replace the formal requirements of target-country regulatory authorities, testing conclusions or legal advice.